| Literature DB >> 24944608 |
Ziying Zou1, Yuan Liu1, Bing Zhu1, Ping Zeng2.
Abstract
A growing number of nontuberculous mycobacteria infection cases, especially those caused by rapidly growing mycobacteria (RGM), have been reported in the past decade. Conventional methods for mycobacteria diagnosis are inefficient and easily lead to misdiagnosis. New detection methods, such as gene sequencing, have been reported but are not widely used. The aim of the present case report was to provide a quick and exact method of identifying Myobacterium abscessus (M. abscessus) infections. The particular case reported in this study initially manifested as hyperglycemia and papules in the right leg. Routine cultures for fungus were repeatedly negative. However, cultures of the purulent material under aerobic cultivation for five days yielded a rapidly growing, nontuberculous mycobacterium. A Ziehl-Neelsen staining of this mycobacterium revealed the presence of acid-fast bacilli that were finally identified as M. abscessus through 16S rDNA sequence analysis and a citrate utilization test. The current report may help other clinicians to make a quick and accurate diagnosis of RGM infection.Entities:
Keywords: 16S rDNA sequence analysis; Mycobacterium abscessus; citrate utilization test; diabetes; rapidly growing mycobacteria
Year: 2014 PMID: 24944608 PMCID: PMC4061238 DOI: 10.3892/etm.2014.1705
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447
Figure 1Multiple skin lesions on the right leg of the patient at admission. There was seropurulent discharge from certain lesions, and some crusts were formed.
Figure 2Acid-fast staining. (A) Ziehl-Neelsen staining of purulent material obtained from a draining lesion reveals multiple acid-fast bacilli (shown by arrows). (B) Direct microscopic examination of cultures of the purulent material following Ziehl-Neelsen staining was positive for acid-fast bacilli. Magnification, ×1,000.
Figure 3Improvement following treatment. The patient’s condition significantly improved with diminishing cutaneous lesions following a week of treatment with intravenous sulfamethoxazole 800 mg twice daily and imipenem 1 g twice daily.